Levin Capital Strategies, L.P. Aerie Pharmaceuticals Inc Transaction History

Levin Capital Strategies, L.P.

$1.03 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$6.37 - $15.23 $656,938 - $1.57 Million	-103,130 Reduced 8.39%	1,125,395 $17 Million
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $1.03 Million - $1.9 Million	-207,351 Reduced 14.44%	1,228,525 $9.21 Million
Q1 2022 May 02, 2022	BUY	$5.64 - $9.8 $3.49 Million - $6.06 Million	618,499 Added 75.67%	1,435,876 $13.1 Million
Q4 2021 Feb 15, 2022	SELL	$7.02 - $13.33 $3.9 Million - $7.41 Million	-556,165 Reduced 40.49%	817,377 $5.74 Million
Q3 2021 Nov 10, 2021	BUY	$11.32 - $16.63 $264,423 - $388,460	23,359 Added 1.73%	1,373,542 $15.7 Million
Q2 2021 Aug 11, 2021	BUY	$15.16 - $18.97 $6.61 Million - $8.28 Million	436,299 Added 47.74%	1,350,183 $21.6 Million
Q1 2021 May 05, 2021	BUY	$13.12 - $20.9 $2.23 Million - $3.55 Million	170,032 Added 22.86%	913,884 $16.3 Million
Q4 2020 Feb 16, 2021	SELL	$9.12 - $14.49 $5.5 Million - $8.74 Million	-603,131 Reduced 44.78%	743,852 $10 Million
Q3 2020 Nov 17, 2020	SELL	$10.46 - $14.46 $4.19 Million - $5.79 Million	-400,118 Reduced 22.9%	1,346,983 $15.9 Million
Q2 2020 Aug 13, 2020	BUY	$12.0 - $16.13 $2.96 Million - $3.97 Million	246,344 Added 16.41%	1,747,101 $25.8 Million
Q1 2020 May 13, 2020	SELL	$11.84 - $25.52 $2.05 Million - $4.43 Million	-173,501 Reduced 10.36%	1,500,757 $20.3 Million
Q4 2019 Feb 10, 2020	BUY	$17.72 - $25.1 $8.57 Million - $12.1 Million	483,652 Added 40.62%	1,674,258 $40.5 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $17.8 Million - $27.1 Million	968,616 Added 436.33%	1,190,606 $22.9 Million
Q2 2019 Aug 13, 2019	BUY	$28.97 - $48.21 $6.29 Million - $10.5 Million	216,990 Added 4339.8%	221,990 $6.56 Million
Q1 2019 May 13, 2019	BUY	$36.32 - $49.25 $181,600 - $246,250	5,000 New	5,000 $237,000

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Account